vs
AETHLON MEDICAL INC（AEMD）与泰利福（TFX）财务数据对比。点击上方公司名可切换其他公司
泰利福净利率更高（177.8% vs -2926.4%，领先3104.1%）。AETHLON MEDICAL INC自由现金流更多（$-2.0M vs $-92.9M）
AETHLON MEDICAL INC是一家临床阶段医疗科技企业，专注开发针对性治疗类医疗器械，核心产品血液净化器可从血液中去除有害病毒、肿瘤外泌体及其他病原体，业务聚焦传染病和肿瘤治疗赛道，主要市场覆盖北美地区。
泰利福（Teleflex）总部位于美国宾夕法尼亚州韦恩，是专业医疗设备供应商，产品广泛应用于重症监护、外科手术等各类诊疗场景。公司年营收达24亿美元，在全球40个国家开展业务，员工总数超15000人。经过数年的收并购与业务剥离，公司于2011年完成业务调整，全面聚焦医疗设备制造领域。
AEMD vs TFX — 直观对比
营收规模更大
AEMD
是对方的-0.0倍
$-401.9M
净利率更高
TFX
高出3104.1%
-2926.4%
自由现金流更多
AEMD
多$90.9M
$-92.9M
损益表 — Q3 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $60.0K | $-401.9M |
| 净利润 | $-1.8M | $-714.3M |
| 毛利率 | — | — |
| 营业利润率 | -3026.4% | — |
| 净利率 | -2926.4% | 177.8% |
| 营收同比 | — | -150.5% |
| 净利润同比 | 49.4% | -422.7% |
| 每股收益（稀释后） | $-10.05 | $-15.85 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AEMDTFX
| Q4 25 | — | $-401.9M | ||
| Q3 25 | — | $913.0M | ||
| Q2 25 | — | $780.9M | ||
| Q1 25 | — | $700.7M | ||
| Q4 24 | $60.0K | $795.4M | ||
| Q3 24 | $95.1K | $764.4M | ||
| Q2 24 | — | $749.7M | ||
| Q1 24 | — | $737.8M |
净利润AEMDTFX
| Q4 25 | — | $-714.3M | ||
| Q3 25 | — | $-408.9M | ||
| Q2 25 | — | $122.6M | ||
| Q1 25 | — | $95.0M | ||
| Q4 24 | $-1.8M | $-136.7M | ||
| Q3 24 | $-2.8M | $111.0M | ||
| Q2 24 | — | $80.0M | ||
| Q1 24 | — | $15.3M |
毛利率AEMDTFX
| Q4 25 | — | — | ||
| Q3 25 | — | 49.5% | ||
| Q2 25 | — | 55.2% | ||
| Q1 25 | — | 55.6% | ||
| Q4 24 | — | 55.3% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.6% | ||
| Q1 24 | — | 56.4% |
营业利润率AEMDTFX
| Q4 25 | — | — | ||
| Q3 25 | — | -44.8% | ||
| Q2 25 | — | 19.9% | ||
| Q1 25 | — | 17.9% | ||
| Q4 24 | -3026.4% | -13.9% | ||
| Q3 24 | -3050.2% | 19.5% | ||
| Q2 24 | — | 15.6% | ||
| Q1 24 | — | -0.6% |
净利率AEMDTFX
| Q4 25 | — | 177.8% | ||
| Q3 25 | — | -44.8% | ||
| Q2 25 | — | 15.7% | ||
| Q1 25 | — | 13.6% | ||
| Q4 24 | -2926.4% | -17.2% | ||
| Q3 24 | -2950.2% | 14.5% | ||
| Q2 24 | — | 10.7% | ||
| Q1 24 | — | 2.1% |
每股收益（稀释后）AEMDTFX
| Q4 25 | — | $-15.85 | ||
| Q3 25 | — | $-9.24 | ||
| Q2 25 | — | $2.77 | ||
| Q1 25 | — | $2.07 | ||
| Q4 24 | $-10.05 | $-2.89 | ||
| Q3 24 | $-16.11 | $2.36 | ||
| Q2 24 | — | $1.69 | ||
| Q1 24 | — | $0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.8M | $378.6M |
| 总债务越低越好 | — | $2.6B |
| 股东权益账面价值 | $4.3M | $3.1B |
| 总资产 | $6.5M | $6.9B |
| 负债/权益比越低杠杆越低 | — | 0.85× |
8季度趋势，按日历期对齐
现金及短期投资AEMDTFX
| Q4 25 | — | $378.6M | ||
| Q3 25 | — | $354.0M | ||
| Q2 25 | — | $253.7M | ||
| Q1 25 | — | $284.1M | ||
| Q4 24 | $4.8M | $290.2M | ||
| Q3 24 | $6.9M | $243.2M | ||
| Q2 24 | — | $238.6M | ||
| Q1 24 | — | $237.4M |
总债务AEMDTFX
| Q4 25 | — | $2.6B | ||
| Q3 25 | — | $2.7B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AEMDTFX
| Q4 25 | — | $3.1B | ||
| Q3 25 | — | $3.8B | ||
| Q2 25 | — | $4.2B | ||
| Q1 25 | — | $4.1B | ||
| Q4 24 | $4.3M | $4.3B | ||
| Q3 24 | $6.0M | $4.5B | ||
| Q2 24 | — | $4.6B | ||
| Q1 24 | — | $4.5B |
总资产AEMDTFX
| Q4 25 | — | $6.9B | ||
| Q3 25 | — | $7.9B | ||
| Q2 25 | — | $7.4B | ||
| Q1 25 | — | $7.2B | ||
| Q4 24 | $6.5M | $7.1B | ||
| Q3 24 | $8.8M | $7.5B | ||
| Q2 24 | — | $7.4B | ||
| Q1 24 | — | $7.5B |
负债/权益比AEMDTFX
| Q4 25 | — | 0.85× | ||
| Q3 25 | — | 0.70× | ||
| Q2 25 | — | 0.45× | ||
| Q1 25 | — | 0.47× | ||
| Q4 24 | — | 0.39× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.0M | $-92.3M |
| 自由现金流经营现金流 - 资本支出 | $-2.0M | $-92.9M |
| 自由现金流率自由现金流/营收 | -3357.0% | 23.1% |
| 资本支出强度资本支出/营收 | 3.7% | -0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $1.4M |
8季度趋势，按日历期对齐
经营现金流AEMDTFX
| Q4 25 | — | $-92.3M | ||
| Q3 25 | — | $107.8M | ||
| Q2 25 | — | $7.8M | ||
| Q1 25 | — | $73.3M | ||
| Q4 24 | $-2.0M | $202.6M | ||
| Q3 24 | $-2.2M | $231.1M | ||
| Q2 24 | — | $91.7M | ||
| Q1 24 | — | $112.8M |
自由现金流AEMDTFX
| Q4 25 | — | $-92.9M | ||
| Q3 25 | — | $77.8M | ||
| Q2 25 | — | $-26.8M | ||
| Q1 25 | — | $43.3M | ||
| Q4 24 | $-2.0M | $170.6M | ||
| Q3 24 | — | $209.9M | ||
| Q2 24 | — | $56.9M | ||
| Q1 24 | — | $74.4M |
自由现金流率AEMDTFX
| Q4 25 | — | 23.1% | ||
| Q3 25 | — | 8.5% | ||
| Q2 25 | — | -3.4% | ||
| Q1 25 | — | 6.2% | ||
| Q4 24 | -3357.0% | 21.4% | ||
| Q3 24 | — | 27.5% | ||
| Q2 24 | — | 7.6% | ||
| Q1 24 | — | 10.1% |
资本支出强度AEMDTFX
| Q4 25 | — | -0.2% | ||
| Q3 25 | — | 3.3% | ||
| Q2 25 | — | 4.4% | ||
| Q1 25 | — | 4.3% | ||
| Q4 24 | 3.7% | 4.0% | ||
| Q3 24 | 0.0% | 2.8% | ||
| Q2 24 | — | 4.6% | ||
| Q1 24 | — | 5.2% |
现金转化率AEMDTFX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 0.77× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.08× | ||
| Q2 24 | — | 1.15× | ||
| Q1 24 | — | 7.38× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
